Epsium Enterprise Limited (NASDAQ:EPSM – Get Free Report) was the target of a significant drop in short interest during the month of May. As of May 15th, there was short interest totaling 7,848 shares, a drop of 39.0% from the April 30th total of 12,873 shares. Approximately 0.1% of the shares of the stock are sold short. Based on an average trading volume of 38,808 shares, the short-interest ratio is presently 0.2 days.
Hedge Funds Weigh In On Epsium Enterprise
Several hedge funds and other institutional investors have recently bought and sold shares of EPSM. PharVision Advisers LLC acquired a new position in Epsium Enterprise during the 3rd quarter worth approximately $118,000. Two Sigma Investments LP acquired a new position in Epsium Enterprise during the 3rd quarter worth approximately $112,000. Finally, JPMorgan Chase & Co. acquired a new position in Epsium Enterprise during the 3rd quarter worth approximately $35,000.
Epsium Enterprise Stock Up 5.1%
NASDAQ EPSM opened at $1.64 on Friday. Epsium Enterprise has a 1-year low of $1.04 and a 1-year high of $155.00. The business’s 50-day simple moving average is $1.36 and its 200-day simple moving average is $1.92.
Analysts Set New Price Targets
Check Out Our Latest Research Report on EPSM
About Epsium Enterprise
We are a holding company incorporated under the laws of British Virgin Islands. As a holding company with no material operation of its own, we conduct substantially all our operations through an indirect Macau subsidiary, Companhia de Comercio Luz Limitada in Macau, or Luz. Luz is an 80%-owned subsidiary of Epsium Enterprise Limited in Hong Kong, or Epsium HK. Mr. Son I Tam, our CEO, Chairman, principal shareholder, and the founder of Epsium and Luz directly holds (i) 89.996% ownership interest in Epsium, (ii) 19% interest in Epsium HK, and (iii) 20% ownership interest in Luz.
Read More
- Five stocks we like better than Epsium Enterprise
- The Great AI Server Rotation Puts Hewlett Packard Enterprise and Super Micro Computer in Focus
- Generac’s AI Power Pivot Raises a Bigger Question About Data Center Demand
- Medtronic Bottoms, Healthy Rebound Ahead
- GitLab’s Price Recovery Gains Traction—Time to Get On Board?
Receive News & Ratings for Epsium Enterprise Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Epsium Enterprise and related companies with MarketBeat.com's FREE daily email newsletter.
